http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201201663-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 2011-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2013-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201201663-A1
titleOfInvention DERIVATIVES 2- (ARYLAMINO) -3H-IMIDAZO [4,5-B] Pyridine-6-carboxamide and their use as MPGES-1 inhibitors
abstract The present invention relates to compounds of formula (I), to their use as inhibitors of microsomal prostaglandin-E-synthase-1 (mPGES-1), to pharmaceutical compositions containing these compounds, and to the use of such compounds as pharmaceuticals intended for treating and / or preventing inflammatory diseases and associated pathological conditions. The values of A, M, W, R, R, R, R are given in the description.
priorityDate 2010-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID544666
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56351
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID102125534
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID64292
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282019
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419580964
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15070
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID9536
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID480698
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID59103
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID473071

Total number of triples: 24.